Allscripts Continues to Lead in Interoperability, Driving Successful Healthcare Delivery

AllscriptsAllscripts (NASDAQ: MDRX) remains committed to effective interoperability in healthcare delivery. A leader in interoperability and open platforms, the company has made it a priority to deliver clinicians accessible, clinically relevant information at the point of care, creating a community patient record and enabling successful care delivery.

Allscripts dbMotion™ Solution has been delivering clinically relevant, meaningful interoperability for many years. With dbMotion, which enables the sharing of data across different EHR systems regardless of vendor, clinicians can engage their care teams and improve access to real-time, harmonized information from across the care continuum. Used around the world in the United States, Australia, Canada, United Kingdom and Israel, the solution leverages and shares data assets, achieving safer high-quality clinical outcomes.

Every month the following volumes are enabled:

  • 14M+ unique patient transactions are received in dbMotion
  • 31,000+ providers and 128,000+ users interact with dbMotion
  • 2,700+ ambulatory and post-acute facilities transmit data with dbMotion
  • 1,000+ hospitals transmit data with dbMotion

Over the past 12 months, dbMotion has achieved significant client success with the sharing of information including:

  • 1B+ pieces of patient demographics data
  • 650M+ observation results
  • 350M+ pharmacy data
  • 289M+ documents
  • 104M+ orders (pharmacy/treatment)
  • 58M+ full patient data records

Allscripts was recently recognized as a growth and innovation top-performing leader in Frost & Sullivan’s Frost Radar™: US Healthcare Data Interoperability Market, 2020. The report states that Allscripts demonstrates superior interoperability across the entire HIT ecosystem by enabling the direct integration of third-party clinical decision support applications into the company’s platforms through on-premise or cloud deployment models.

"Allscripts has advocated for having an open platform since 2007 and we believe interoperability is the foundation for advancing healthcare - data and access should be Open. For Everyone™," said Allscripts Chief Executive Officer, Paul M. Black. "Our systems - all of them - should be able to talk to each other. Through dbMotion, we have helped providers all around the world collaborate, deliver higher-quality care, lower costs and help consumers achieve better outcomes. We are proud of the interoperability tools we offer, creating a health ecosystem where critical data is made useful by combining isolated islands of community information into a single, actionable patient record. We remain committed to assisting in successful healthcare delivery for today and tomorrow."

About Allscripts

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers and consumers to make better decisions, delivering better care for healthier populations.

Most Popular Now

Open Call HORIZON-JU-IHI-2022-03-05: Dig…

Mental health disorders represent an area of severe unmet public health need. This has been further negatively impacted by the COVID-19 pandemic, with a substantial increase in the number and...

The Future of Medicine is Data

At the 2023 Annual J.P. Morgan Healthcare Conference, Owkin Co-founder and CEO Thomas Clozel, MD will outline how data is the future of medicine - from the development of new...

Brain Area Necessary for Fluid Intellige…

A team led by UCL and UCLH researchers have mapped the parts of the brain that support our ability to solve problems without prior experience - otherwise known as fluid...

Study Surveys Landscape of Apps Built on…

A study led by Regenstrief Institute Research Scientist Titus K. Schleyer, DMD, PhD, is among the first to survey the current landscape of FHIR® apps, providing a snapshot of how...

New Computer Program 'Learns' to Identif…

Genetic mutations cause hundreds of unsolved and untreatable disorders. Among them, DNA mutations in a small percentage of cells, called mosaic mutations, are extremely difficult to detect because they exist...

Applications Open for SpinLab Accelerato…

The start-up accelerator supports entrepreneurial and innovative teams that want to grow sustainably and successfully scale their business model. With a strong hands-on mentality and a lot of passion, the...

Allscripts Announces Corporate Name Chan…

Allscripts Healthcare Solutions, Inc. announced that, effective January 1, 2023, it has changed its name to Veradigm Inc. (NASDAQ: MDRX). Allscripts had been transitioning its solutions to the Veradigm brand...

Bayer to Accelerate Drug Discovery with …

Bayer AG and Google Cloud today announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-developed accelerators designed to run...

220M€ Investment in Testing and Experime…

To make the EU the place where AI excellence thrives from the lab to the market, the European Union is setting up world-class Testing and Experimentation Facilities (TEFs) for AI. Together...

Artificial Nerve Cells - Almost Like Bio…

Researchers at Linköping University (LiU), Sweden, have created an artificial organic neuron that closely mimics the characteristics of biological nerve cells. This artificial neuron can stimulate natural nerves, making it...

AI Tool Developed to Predict Risk of Lun…

Lung cancer is the leading cause of cancer death in the United States and around the world. Low-dose chest computed tomography (LDCT) is recommended to screen people between 50 and...

For Shared Decision-Making, Telemedicine…

Telemedicine may be just as effective as in-person visits when it comes to shared decision-making and communication for patients undergoing a first-time surgery consultation, according to a study published as...